JCM
GILD icon

Jafra Capital Management’s Gilead Sciences GILD Stock Holding History

Jafra Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-20,453
Closed -$1.54M – 91
2018
Q1 		$1.54M Buy
+20,453
New +$1.63M 0.48% 58
2017
Q3 		– Sell
-52,571
Closed -$3.72M – 85
2017
Q2 		$3.72M Buy
+52,571
New +$3.5M 1.38% 24

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jafra Capital Management's GILD Position: Q2 2018 in Review

Jafra Capital Management sold out of Gilead Sciences (GILD) in Q2 2018, closing a stake of 20,453 shares — an estimated $1.54M sold.

Jafra Capital Management first reported a position in GILD in Q2 2017 and held it in 2 quarters. The position peaked at $3.72M in Q2 2017. 1,523 funds tracked by Wall St. Rank hold GILD as of Q2 2018.

  • Jafra Capital Management reported no remaining Gilead Sciences position as of Q2 2018 after selling out during the quarter.
  • Jafra Capital Management sold 20,453 Gilead Sciences shares in Q2 2018, an estimated $1.54M.
  • Jafra Capital Management first reported a position in Gilead Sciences in Q2 2017 and held it in 2 quarters.
  • Jafra Capital Management's Gilead Sciences position peaked at $3.72M in Q2 2017.
  • 1,523 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2018.

Based on Jafra Capital Management's 13F filing for Q2 2018, filed 15 Aug 2018.